Healthcare diagnostics startup Neuranics raises $700K in seed round

Neuranics, a healthcare diagnostics startup, has raised $700K in its seed round led by Inflection Point Ventures (IPV). 

The proceeds will be used for technology development and clinical validation, enabling the company to progress toward commercial production post-CDSCO licensing. 

Founded in 2021 by Praveen Kumar and Ashutosh Patra, Neuranics is developing a point-of-care blood analyzer capable of delivering complete blood count (CBC) results in less than 10 minutes using just a finger-prick sample. The device, designed for primary and emergency settings, offers low maintenance and high efficiency, making it a game-changer for the healthcare industry.

At the same time, life-saving treatments for critical conditions like sepsis, severe anemia, and thrombocytopenia, especially in dengue patients, can be initiated promptly, ensuring timely and effective care. 

The company has a patent granted, received the CDSCO Test License, and Ethical Approval from AIIMS Delhi, and progressing through clinical trials. 

So far, Inflection Point Ventures has invested over Rs 790 crore across over 210 startups.